Equillium, Inc. (EQ)
NASDAQ·Healthcare·Biotechnology
$2.05
+0.25%
Mkt Cap $72.46M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | — | — | — | -$0.07 | -$0.04 | +42.86% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.14 | -$0.06 | +57.14% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.14 | -$0.16 | -14.29% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.23 | -$0.24 | -4.35% | — | — |
| Q1 2025 Mar 27, 2025 | — | $4.39M | — | -$0.22 | -$0.16 | +27.27% | — | — |
| Q4 2024 Nov 13, 2024 | $11.55M | $12.16M | +5.29% | -$0.26 | -$0.00 | +99.92% | — | — |
| Q3 2024 Aug 8, 2024 | $21.40M | $13.85M | -35.27% | -$0.15 | $0.01 | +106.67% | — | — |
| Q2 2024 May 9, 2024 | $9.00M | $10.69M | +18.77% | -$0.17 | -$0.08 | +52.94% | — | — |
| Q1 2024 Mar 25, 2024 | $8.00M | $9.21M | +15.14% | -$0.17 | -$0.07 | +58.82% | — | — |
| Q4 2023 Nov 8, 2023 | $8.00M | $8.87M | +10.88% | -$0.16 | -$0.11 | +31.25% | — | — |
| Q3 2023 Aug 9, 2023 | $8.00M | $9.12M | +14.05% | -$0.19 | -$0.10 | +47.37% | — | — |
| Q2 2023 May 11, 2023 | $4.60M | $8.88M | +93.02% | -$0.20 | -$0.11 | +45.00% | — | — |
| Q1 2023 Mar 23, 2023 | $38.00M | $15.76M | -58.53% | $0.02 | $0.08 | +407.61% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.39 | -$0.40 | -2.56% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.40 | -$0.41 | -2.50% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.36 | -$0.45 | -25.00% | — | — |
| Q1 2022 Mar 23, 2022 | — | — | — | -$0.34 | -$0.36 | -5.88% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.34 | -$0.35 | -2.94% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$0.31 | -$0.31 | +0.00% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.34 | -$0.33 | +2.94% | — | — |